These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 6564900)

  • 21. WHO Expert Committee on specifications for pharmaceutical preparations.
    World Health Organ Tech Rep Ser; 1996; 863():1-194. PubMed ID: 8952445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The isolation and identification of precursors and reaction products in the clandestine manufacture of methaqualone and mecloqualone.
    Angelos SA; Meyers JA
    J Forensic Sci; 1985 Oct; 30(4):1022-47. PubMed ID: 3840834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmaceutical reimportation: magnitude, trends, and consumers.
    Saatsoglou P
    Manag Care; 2004 Mar; 13(3 Suppl):7-9. PubMed ID: 15074162
    [No Abstract]   [Full Text] [Related]  

  • 24. Chemical hazards related to clandestine drug laboratories.
    Hughart JL
    Arh Hig Rada Toksikol; 2000 Sep; 51(3):305-10. PubMed ID: 11148935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. International co-operation through the Interpol system to counter illicit drug trafficking.
    Leamy WJ
    Bull Narc; 1983; 35(4):55-60. PubMed ID: 6563926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rx: Canadian drugs.
    Rawson NS
    N Engl J Med; 2004 Mar; 350(11):1155. PubMed ID: 15017685
    [No Abstract]   [Full Text] [Related]  

  • 27. Clandestine methamphetamine labs in Wisconsin.
    Vandeveld N
    J Environ Health; 2004 Mar; 66(7):46-51. PubMed ID: 15032112
    [No Abstract]   [Full Text] [Related]  

  • 28. [Illicit market of controlled drugs in Italy: new drugs and trends].
    Schiavone S
    Ann Ist Super Sanita; 2002; 38(3):315-8. PubMed ID: 12645183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [New, previously unavailable on the illegal drug market amphetamine derivatives with a partial propiophenone structure].
    Fritschi G; Klein B; Rösner P
    Arch Kriminol; 1997; 200(1-2):8-16. PubMed ID: 9382691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug production, trafficking and trade in Asia and Pacific Island countries.
    Reid G; Devaney ML; Baldwin S
    Drug Alcohol Rev; 2006 Nov; 25(6):647-50. PubMed ID: 17132580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality control of drugs: certification scheme on the quality of pharmaceutical products moving in international commerce.
    WHO Chron; 1980 Nov; 34(11):427-32. PubMed ID: 7467274
    [No Abstract]   [Full Text] [Related]  

  • 32. Deterring the importation of counterfeit pharmaceutical products.
    Stearn DW
    Food Drug Law J; 2004; 59(4):537-61. PubMed ID: 15875351
    [No Abstract]   [Full Text] [Related]  

  • 33. The activities of the Narcotics Laboratory Section of the Division of Narcotic Drugs in supporting national laboratories. United Nations Secretariat.
    Bull Narc; 1984; 36(1):69-74. PubMed ID: 6564905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double standards in GMP deduplication row.
    Hodgson J; Fox JL
    Nat Biotechnol; 1996 Dec; 14(13):1647-8. PubMed ID: 9634839
    [No Abstract]   [Full Text] [Related]  

  • 35. Designer drugs: a medicinal chemistry perspective.
    Carroll FI; Lewin AH; Mascarella SW; Seltzman HH; Reddy PA
    Ann N Y Acad Sci; 2012 Feb; 1248():18-38. PubMed ID: 22092008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Designer drugs: past history and future prospects.
    Henderson GL
    J Forensic Sci; 1988 Mar; 33(2):569-75. PubMed ID: 3286815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Chemical compound safety: typology of competency accreditation for assay centers and analytical laboratories].
    Menditto A; Chiodo F
    Ann Ist Super Sanita; 2002; 38(1):77-85. PubMed ID: 12122899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality control of drugs. Certification scheme on the quality of pharmaceutical products moving in international commerce.
    WHO Chron; 1979; 33(7-8):289-94. PubMed ID: 483787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The United States drug problem and international trafficking. Part I. The need for more rigorous controls.
    Lockwood RS
    Int J Addict; 1977 Aug; 12(5):633-50. PubMed ID: 924697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Legalized importation of Canadian prescription drugs: short-term solution to a long-term problem.
    Teufel AT
    J Contemp Health Law Policy; 2006; 22(2):383-408. PubMed ID: 17117702
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.